Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
14.62 EUR | -1.35% | -3.69% | +48.88% |
04-29 | Abivax: share price rises as two analysts express optimism | CF |
04-29 | Piper Sandler Starts Abivax With Overweight Rating, $42 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.88% | 999M | |
+1.77% | 42.86B | |
+43.74% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- ABVX Stock
- News Abivax
- Abivax Gets EU Support To Advance Ulcerative Colitis Drug Into Late-Stage Trial